Medication info
Jovatorin Tablets 10/10 mg (Ezetimibe/Simvastatin)

Jovatorin Tablets 10/10 mg (Ezetimibe/Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
White to off-white, biconvex, rectangular tablets
Packaging
30 Tablets (10 Tablets/Blister Package X 3)
Approval status
Active

MFDS item code 201602085 · Approved 2016.04.12 · Insurance code 693202710

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. Check blood lipid levels and adjust the dose at intervals of at least 4 weeks after starting treatment or adjusting the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be prescribed only to patients who have taken 10/80 mg of this medicine for at least 12 months without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Use in patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine with caution in these patients and monitor them carefully (see 5. General Precautions under Precautions for Use). Use in elderly patients No dose adjustment is required in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
  • increased risk of atherosclerotic cardiovascular diseases due to hypercholesterolemia.
View approved original text

This medication is used as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides in patients with primary hypercholesterolemia and mixed hyperlipidemia, and to increase HDL cholesterol. Especially in patients with homozygous familial hypercholesterolemia, it may be administered when other lipid-lowering therapies are ineffective or as an adjunctive therapy. This drug should be used together with an appropriate diet, including restrictions on saturated fat and cholesterol, and is used when there is insufficient response to non-drug measures. Additionally, it is important to confirm and treat secondary causes such as diabetes and hypothyroidism before administration. This drug helps improve blood lipid levels in patients, reducing the risk of atherosclerotic cardiovascular diseases caused by hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require a smaller reduction in LDL cholesterol may start with 10/10mg once daily. Check blood lipid levels and adjust the dose at intervals of at least 4 weeks after starting treatment or adjusting the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be prescribed only to patients who have taken 10/80 mg of this medicine for at least 12 months without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Use in patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine with caution in these patients and monitor them carefully (see 5. General Precautions under Precautions for Use). Use in elderly patients No dose adjustment is required in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This drug is used to lower blood cholesterol levels. Symptoms such as muscle pain or weakness may occur during treatment, so if these symptoms appear, you must inform your doctor immediately. Particularly, the risk of muscle-related side effects may increase when taken at high doses or with certain other medications. This drug may affect liver function, so it should not be taken by individuals with liver disease or abnormal liver function test results. Women who are pregnant or breastfeeding should not take this drug, and women who may become pregnant must confirm their pregnancy status before taking it. Additionally, the risk of side effects may increase when taken with certain enzyme-inhibiting drugs, so you should inform your doctor or pharmacist of any medications you are taking. Caution is needed for elderly patients and children, especially those under 10 years old, as safety has not been fully established. Regular blood tests to check liver function and muscle enzyme levels are recommended during treatment. In case of overdose, general treatment for symptoms will be provided as there is no specific antidote. During treatment with this medication, grapefruit juice and certain drug combinations should be avoided, and healthcare professionals should be informed of this medication when starting new drugs.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 99 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • dysgeusia
  • ophthalmoplegia
  • facial hemiparesis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disturbances
  • impaired memory
  • forgetfulness
  • amnesia
  • memory disorders
  • confusion
  • interstitial lung disease
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • biliary stasis jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • erectile dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • increased γ-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. Additionally, it is recommended to store the medication at room temperature, between 1 to 30 degrees Celsius, avoiding excessively high or low temperatures.

Appearance and packaging

Appearance

White to off-white, biconvex, rectangular tablets

Package unit

30 Tablets (10 Tablets/Blister Package X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.